Patent US4639512A successfully refreshed from Google Patents.
US4639512A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Conjugates of haptenes and muramyl-peptides, endowed with immunogenic activity and compositions containing them
Assignee: HEBERT ETIENNE
•
Filing: 1983-03-11
•
Granted: 1987-01-27
•
Expires: 2003-03-11
Abstract
Abstract The invention relates to an immunogenic principle containing a specific antigen determinant of a predetermined native antigen. This immunogenic principle is constituted by a conjugate between a hapten bearing said antigenic site and a muramyl-peptide, essentially in the absence of supporting macromolecules, this conjugate having an immunogenic effect not only against itself, but also with respect to the native antigen carrying said antigenic site.
Inventors
- 👤 Francoise Audibert
- 👤 Claude Carelli
- 👤 Louis Chedid
- 👤 Pierre LeFrancier
- 👤 Michel Level
- 👤 Jean Choay
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 14:28
CPC Classifications
A; A61; A61K; A61K39/00; A61K39/385; C; C07; C07K; C07K9/00; C07K9/001; C07K9/005; A61K2039/60; A61K2039/6031; A61K2039/6062; Y; Y02; Y02A; Y02A50/00; Y02A50/30; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/13; Y10S930/15; Y10S930/16
Claims Analysis
Total Claims: 27
Claim 1
Independent Claim
571 words
An immunogenic and apyrogenic conjugate consisting essentially of a hapten covalently linked to a muramyl peptide, which conjugate comprises a molecular weight which does not exceed 5000, wherein the hapten is selected from the group consisting of peptides, glycopeptides, oligosaccharides, lipopeptides, glycolipids, lipids and steroids which are incapable of inducing an immunological response in vivo except when bound to an immunological carrier; and wherein the muramyl peptide part conjugated to the hapten is derived from the muramyl peptide which has the general formula (I): ##STR8## in which the following groups, when not covalently linked to the hapten, have the following meaning: R 5 is a free carboxyl group or amido group, or a carboxyl group esterified by an aliphatic alcohol possessing from 1 to 10 carbon atoms, or a carboxyl group substituted by an amino acid possessing itself a free carboxyl group or an amidated group or a carboxyl group esterified by an aliphatic alcohol possessing from 1 to 10 carbon atoms, R is a hydrogen or a methyl group, R 2 is an acetamido or a glycoyl-amido group, R 1 is either --NH 2 , or OH, or a radical comprising at the most 10 carbon atoms, corresponding to an alkyl, aryl, arylalkyl or alkylaryl group, optionally bearing hydroxyl-, amido, carboxamido-, sulfonamido-, ether, thioether, ester- or thioester substituents R 4 is a hydroxyl or an oxyacyl group comprising from 1 to 4 carbon atoms, X is an aminoacyl residue of the group comprising: alanyl, arginyl, asparagyl, aspartyl, cysteinyl, glutaminyl, glutamyl, glycyl, histidyl, hydroxy-prolyl isoleucyl, leucyl, lysyl, methionyl, phenylalanyl, prolyl, seryl, threonyl, tryptophanyl, tyrosyl, valyl and aminobutyryl, Z is a group substituting the position at C-6 of muramic acid, and which has the following general formula (II): --R.sub.6 --(R.sub.7).sub.x in which x=0 or 1 and in which, if x=0, R 6 is hydroxyl or amino and, if x=1, R 6 is hydroxyl group or amino, carboxamido, sulfonamide ether or thioether, ester or thioester, R 7 then being a chain of --CH 2 , --CH═CH--, --S--, --CO-- or NH groups, --CH 2 --; --CH═CH--, or NH-groups, said groups being optionally replaced or substituted by aryl groups or by carboxlyic, amino, sulfhydryl or hydroxyl groups, or by alkyl groups including up to 5 carbon atoms or by alkylaryl groups, arylalkyl including in all up to 8 carbon atoms or by heterocyclic groups including up to six carbon atoms and one or two oxygen, nitrogen or sulfur atoms, said alkylaryl or arylalkyl groups optionally containing carbonyl groups or being optionally substituted by carboxyl, amino, sulfhydryl or hydroxyl groups, said heterocyclic groups being themselves optionally substituted by alkyl groups which can contain up to 5 carbon atoms, carboxyl, amino, sulfhydryl or hydroxyl, the above said R 7 group having none the less a length not exceeding that of an n-decyl hydrocarbon chain, Y is a free or amidated carboxyl group, or an ester group comprising up to 10 carbon atoms, or substituted by an amino acid or is a group of formula (III): --R.sub.8 --(R.sub.9).sub.x (III) in which x equals 0 or 1 and in which R 8 is an amide or ester linkage when x is equal to zero, or when x is different from zero, R 8 is a carboxamido-, ester- or thioester-group, R 9 then having the same meaning as R 7 ; and which conjugate when administered in vivo elicits only antibodies or a cell mediated immunological response involving the hapten.
Claim 2
Dependent Claim
571 words
An immunogenic and apyrogenic conjugate consisting essentially of a hapten covalently linked to a muramyl peptide, which conjugate comprises a molecular weight which does not exceed 5000, wherein the hapten is selected from the group consisting of peptides, glycopeptides, oligosaccharides, lipopeptides, glycolipids, lipids and steroids which are incapable of inducing an immunological response in vivo except when bound to an immunological carrier; and wherein the muramyl peptide part conjugated to the hapten is derived from the muramyl peptide which has the general formula (I): ##STR8## in which the following groups, when not covalently linked to the hapten, have the following meaning: R 5 is a free carboxyl group or amido group, or a carboxyl group esterified by an aliphatic alcohol possessing from 1 to 10 carbon atoms, or a carboxyl group substituted by an amino acid possessing itself a free carboxyl group or an amidated group or a carboxyl group esterified by an aliphatic alcohol possessing from 1 to 10 carbon atoms, R is a hydrogen or a methyl group, R 2 is an acetamido or a glycoyl-amido group, R 1 is either --NH 2 , or OH, or a radical comprising at the most 10 carbon atoms, corresponding to an alkyl, aryl, arylalkyl or alkylaryl group, optionally bearing hydroxyl-, amido, carboxamido-, sulfonamido-, ether, thioether, ester- or thioester substituents R 4 is a hydroxyl or an oxyacyl group comprising from 1 to 4 carbon atoms, X is an aminoacyl residue of the group comprising: alanyl, arginyl, asparagyl, aspartyl, cysteinyl, glutaminyl, glutamyl, glycyl, histidyl, hydroxy-prolyl isoleucyl, leucyl, lysyl, methionyl, phenylalanyl, prolyl, seryl, threonyl, tryptophanyl, tyrosyl, valyl and aminobutyryl, Z is a group substituting the position at C-6 of muramic acid, and which has the following general formula (II): --R.sub.6 --(R.sub.7).sub.x in which x=0 or 1 and in which, if x=0, R 6 is hydroxyl or amino and, if x=1, R 6 is hydroxyl group or amino, carboxamido, sulfonamide ether or thioether, ester or thioester, R 7 then being a chain of --CH 2 , --CH═CH--, --S--, --CO-- or NH groups, --CH 2 --; --CH═CH--, or NH-groups, said groups being optionally replaced or substituted by aryl groups or by carboxlyic, amino, sulfhydryl or hydroxyl groups, or by alkyl groups including up to 5 carbon atoms or by alkylaryl groups, arylalkyl including in all up to 8 carbon atoms or by heterocyclic groups including up to six carbon atoms and one or two oxygen, nitrogen or sulfur atoms, said alkylaryl or arylalkyl groups optionally containing carbonyl groups or being optionally substituted by carboxyl, amino, sulfhydryl or hydroxyl groups, said heterocyclic groups being themselves optionally substituted by alkyl groups which can contain up to 5 carbon atoms, carboxyl, amino, sulfhydryl or hydroxyl, the above said R 7 group having none the less a length not exceeding that of an n-decyl hydrocarbon chain, Y is a free or amidated carboxyl group, or an ester group comprising up to 10 carbon atoms, or substituted by an amino acid or is a group of formula (III): --R.sub.8 --(R.sub.9).sub.x (III) in which x equals 0 or 1 and in which R 8 is an amide or ester linkage when x is equal to zero, or when x is different from zero, R 8 is a carboxamido-, ester- or thioester-group, R 9 then having the same meaning as R 7 ; and which conjugate when administered in vivo elicits only antibodies or a cell mediated immunological response involving the hapten.
Claim 3
Dependent Claim
14 words
The conjugate of claim 1, wherein the hapten is a peptide or a glycopeptide.
Claim 4
Dependent Claim
14 words
The conjugate of claim 1, wherein the hapten comprises a hormone or part thereof.
Claim 5
Dependent Claim
13 words
The conjugate of claim 1 which has a molecular weight less than 3,000.
Claim 6
Dependent Claim
13 words
The conjugate of claim 4 which has a molecular weight less than 2,000.
Claim 7
Dependent Claim
17 words
The conjugate of claim 1, wherein the hapten is a peptide of less than 50 aminoacyl residues.
Claim 8
Dependent Claim
17 words
The conjugate of claim 6, wherein the hapten is a peptide of less than 30 aminoacyl residues.
Claim 9
Dependent Claim
17 words
The conjugate of claim 7, wherein the hapten is a peptide of less than 20 aminoacyl residues.
Claim 10
Dependent Claim
17 words
The conjugate of claim 1, wherein the muramyl peptide, when not conjugated with the hapten, is pyrogenic.
Claim 11
Dependent Claim
23 words
The conjugate of claim 1, wherein the hapten comprises an antigenic site which has the structure of a portion of a natural antigen.
Claim 12
Dependent Claim
22 words
The conjugate of claim 1, wherein the antigenic site is a peptide which possess a sequence present in a native peptide antigen.
Claim 13
Dependent Claim
15 words
The conjugate of claim 1, wherein the hapten comprises at least one mono- or polysaccharide.
Claim 14
Dependent Claim
14 words
The conjugate of claim 12, wherein the polysaccharide is a hexose or a pentose.
Claim 15
Dependent Claim
13 words
The conjugate of claim 1, 11 or 12, wherein the hapten is synthetic.
Claim 16
Dependent Claim
17 words
The conjugate of claim 1, wherein X is a glycyl, seryl, valyl, leucyl, aminobutyryl residue, or alanyl.
Claim 17
Dependent Claim
18 words
The conjugate of claim 1, wherein, x being equal to zero, Z is a hydroxyl or amino function.
Claim 18
Dependent Claim
91 words
The conjugate of claim 1, wherein: x=1, R 6 is a carboxamide linkage or sulphonamide either or thioether, ester or thioester, and R 7 represents one of the groups such as those indicated below (CH 2 ) n --COOH, particularly with n=1, 2, 3 or 4 (CH 2 ) n --NH 2 , particularly with n=1, 2, 3 or 4 ##STR9## particularly with n=1, 2, 3 or 4 (CH 2 ) n --C 6 H 5 --NH 2 , particularly with n=0 or 1 (CH 2 ) n --SH, particularly n=2.
Claim 19
Dependent Claim
32 words
The conjugate of claim 1, wherein the R 5 group is a carboxyl function esterified by an alcohol comprising from 1 to 5 carbon atoms and Y is a --CONH 2 group.
Claim 20
Dependent Claim
17 words
The conjugate of claim 1, wherein the group R of the muramyl-peptide group is a methyl group.
Claim 21
Dependent Claim
17 words
The conjugate of claim 1, wherein the group Z of the muramyl-peptide portion is a succinyl group.
Claim 22
Dependent Claim
54 words
The conjugate of claim 1, wherein R 1 , R 4 and R 6 are hydroxyls and R 2 is acetamido, R is a methyl group, X is an alanyl group, R 5 is a carboxamide group or an ester group including from 1 to 5 carbon atoms, and Y is a carboxamide function.
Claim 23
Dependent Claim
48 words
The conjugate of claim 1, whrein the muramylpeptide portion is selected from one of the following muramylpeptides: N-acetyl-muramyl-L-alanyl-D-isoglutamine, a-n.butyl-ester of N-acetyl-muramyl-L-alanyl-D-glutamine, 6-O-succinylated derivatives of the two foregoing muramylpeptides, a mono-a- or y-ester or a diester of N-acetyl-muramyl-L-alanyl-D-glutamic acid, wherein ester groups contain from 1 to 5 carbon atoms.
Claim 24
Dependent Claim
11 words
The conjugate of claim 1, wherein Y includes a lysyl group.
Claim 25
Dependent Claim
11 words
The conjugate of claim 15 wherein the muramylpeptide portion is N-acetyl-muramyl-L-alanyl-D-isoglutaminyl-L-lysine.
Claim 26
Dependent Claim
6 words
The conjugate which consists of (LH--RH)--N--acetyl-muramyl-L-alanyl-D-isoglutamine-L-lysine.
Claim 27
Dependent Claim
6 words
The conjugate which consists of (LH--RH)--N--acetyl-muramyl-L-alanyl-D-isoglutamine-L-lysine.
References Cited (Backward Citations)
US4397844A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-01-26 | 1990-07-28 | 1991-01-27 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-01-26 | 1994-07-28 | 1995-01-27 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-01-26 | 1998-07-28 | 1999-01-27 | $7700.00 | Window Closed / Lapsed |